Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy).
Combined delta2H, delta13C and delta15N isotopic analysis of MDA and MDMA extracted from seized "ecstasy" tablets provides an isotopic "fingerprint" of the active ingredient allowing individual tablets to be linked to a common batch. Correlating these data with 2H NMR analysis of the extracts has the potential to study both the natural precursor materials and synthetic pathways used in the preparation of MDA and N-substituted homologues.
Carter
James F
JF
Organic and Biological Section, School of Chemistry, University of Bristol, Cantock's Close, UK. jim.carter@bristol.ac.uk
Titterton
a Emma L
aE
Murray
Martin
M
Sleeman
Richard
R
D015104:3,4-Methylenedioxyamphetamine / Q000032:analysis*; D004335:Drug and Narcotic Control; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods; D013287:Illicit Drugs / Q000737:chemistry*; D009682:Magnetic Resonance Spectroscopy; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000032:analysis*; D012680:Sensitivity and Specificity
D013287:Illicit Drugs; D015104:3,4-Methylenedioxyamphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine